Lucinda Billingham

University of Birmingham - Cancer Research Clinical Trials Unit

Lucinda Billingham BSc MSc PhD CStat
Lucinda Billingham is Professor of Biostatistics within the Institute of Cancer and Genomic Sciences at the University of Birmingham. She has worked for over twenty years as a Biostatistician at their Cancer Research UK Clinical Trials Unit and is now Director of Biostatistics for the Unit working with a large team of Biostatisticians on an extensive portfolio of early and late phase trials. Lucinda has a special interest in lung cancer research and is the Chief Biostatistician for the National Lung Matrix Trial. She is a member of the British Thoracic Oncology Group Steering Committee and is an invited member of the Cancer Research UK Clinical Expert Review Panel providing statistical advice for funding applications. She lectures on a number of undergraduate and postgraduate courses at Birmingham, teaches widely on external courses and provides PhD supervision.

dont miss

National Lung Matrix Trial: testing multiple novel targeted treatments

The National Lung Matrix Trial (NLMT) is a flagship trial in the United Kingdom being the first to combine the development of a technology platform that screens for multiple genetic aberrations in lung tumours (provided by the Cancer Research UK Stratified Medicine Programme) with testing of multiple novel genetic-marker-directed drugs. This presentation will summarise the challenges encountered with design, implementation and reporting of this umbrella-basket phase II platform trial.

EVEN MORE SEMINARS

  • Mr Hamish Clouston: Speaking at the Oncology Convention

    Mr Hamish Clouston
    The Christie NHS Foundation Trust

    Surgical Management of Advanced Colonic and Rectal Malignancies.

  • Professor Anthony Howell: Speaking at the Oncology Convention

    Professor Anthony Howell
    The University of Manchester / The Christie NHS Foundation Trust

    Improving risk estimation of breast cancer

  • Professor Robert Thomas: Speaking at the Oncology Convention

    Professor Robert Thomas
    Bedford and Addenbrooke's Cambridge University Hospitals

    Evidence based lifestyle strategies after cancer - a research review

  • Professor Noel Clarke: Speaking at the Oncology Convention

    Professor Noel Clarke
    The Christie and Salford Royal Hospitals, Manchester UK

    Improving Prostate Cancer Outcomes Through Cancer Trials

  • Prof Ingunn Holen: Speaking at the Oncology Convention

    Prof Ingunn Holen
    Department of Oncology and Metabolism, University of Sheffield, UK

    Tumour cell dormancy and breast cancer relapse